Cited by 1,486HIV Research and TreatmentRNA regulation and diseaseHIV/AIDS drug development and treatment

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

Open access

Mangeat, Bastien, Turelli, Priscilla, Caron, Gersende, Friedli, Marc, Perrin, Luc, Trono, Didier·2003·Nature

Open this paper in CoChat — free account

Abstract

Viral replication usually requires that innate intracellular lines of defence be overcome, a task usually accomplished by specialized viral gene products. The virion infectivity factor (Vif) protein of human immunodeficiency virus (HIV) is required during the late stages of viral production to counter the antiviral activity of APOBEC3G (apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G; also known as CEM15), a protein expressed notably in human T lymphocytes. When produced in the presence of APOBEC3G, vif-defective virus is non-infectious. APOBEC3G is closely related to APOBEC1, the central component of an RNA-editing complex that deaminates a cytosine residue in apoB messenger RNA. APOBEC family members also have potent DNA mutator activity through dC deamination; however, whether the editing potential of APOBEC3G has any relevance to HIV inhibition is unknown. Here, we demonstrate that it does, as APOBEC3G exerts its antiviral effect during reverse transcription to trigger G-to-A hypermutation in the nascent retroviral DNA. We also find that APOBEC3G can act on a broad range of retroviruses in addition to HIV, suggesting that hypermutation by editing is a general innate defence mechanism against this important group of pathogens.

Integrity signals

Registry

Crossref · 10.1038/nature01709

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,407
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
Self-citation
A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine
Powell, L. M., Wallis, S. C., Pease, R. J., Edwards, Y. H., Knott, T. J., & Scott, J. (1987) · Cell · doi:10.1016/0092-8674(87)90510-1 · Cited by 1,039
Transcription-targeted DNA deamination by the AID antibody diversification enzyme
Chaudhuri, J., Tian, M., Khuong, C., Chua, K. F., Pinaud, E., & Alt, F. W. (2003) · Nature · doi:10.1038/nature01574 · Cited by 746
An Anthropoid-Specific Locus of Orphan C to U RNA-Editing Enzymes on Chromosome 22
Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., & Navaratnam, N. (2002) · Genomics · doi:10.1006/geno.2002.6718 · Cited by 711
A quantitative assay for HIV DNA integration in vivo
Butler, S. L., Hansen, M. S., & Bushman, F. D. (2001) · Nature Medicine · doi:10.1038/87979 · Cited by 695
RNA Editing Enzyme APOBEC1 and Some of Its Homologs Can Act as DNA Mutators
Harris, R. S., Petersen‐Mahrt, S. K., & Neuberger, M. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00742-6 · Cited by 609
Molecular Cloning of an Apolipoprotein B Messenger RNA Editing Protein
Teng, B., Burant, C. F., & Davidson, N. O. (1993) · Science · doi:10.1126/science.8511591 · Cited by 536
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes
Gabuzda, D. H., Lawrence, K., Langhoff, E., Terwilliger, E., Dorfman, T., Haseltine, W. A., & Sodroski, J. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6489-6495.1992 · Cited by 444
Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells
von Schwedler, U. K., Song, J., Aiken, C., & Trono, D. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4945-4955.1993 · Cited by 441
Self-citation

Flagged first, then by citations

Show all 28 references

Sorted by citations

Items 801–900 of 1,001

APOBEC3G cytidine deaminase association with coronavirus nucleocapsid protein
Wang, S.-M., & Wang, C.-T. (2009) · Virology · doi:10.1016/j.virol.2009.03.010 · Cited by 24
G‐to‐A Hypermutation in Hepatitis B Virus (HBV) and Clinical Course of Patients with Chronic HBV Infection
Noguchi, C., Imamura, M., Tsuge, M., Hiraga, N., Mori, N., Miki, D., Kimura, T., Takahashi, S., Fujimoto, Y., Ochi, H., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/598951 · Cited by 24
Multi-Scale Modeling of HIV Infection in vitro and APOBEC3G-Based Anti-Retroviral Therapy
Hosseini, I., & Gabhann, F. M. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002371 · Cited by 24
The role of Vif oligomerization and RNA chaperone activity in HIV-1 replication
Batisse, J., Guerrero, S. X., Bernacchi, S., Sleiman, D., Gabus, C., Darlix, J., Marquet, R., Tisné, C., & Paillart, J. (2012) · Virus Research · doi:10.1016/j.virusres.2012.06.018 · Cited by 29
Upregulation of Innate Antiviral Restricting Factor Expression in the Cord Blood and Decidual Tissue of HIV-Infected Mothers
Pereira, N. Z., Cardoso, E. C., Oliveira, L. M. D. S., de Lima, J. F., Branco, A. C. C. C., Ruocco, R. M. D. S. A., Zugaib, M., Oliveira, J. B., Duarte, A. J. D. S., & Sato, M. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084917 · Cited by 24
AID and Apobec3G haphazard deamination and mutational diversity
Jaszczur, M. M., Bertram, J. G., Pham, P., Scharff, M. D., & Goodman, M. F. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1212-1 · Cited by 24
Deep Sequencing of HIV-1 RNA and DNA in Newly Diagnosed Patients with Baseline Drug Resistance Showed No Indications for Hidden Resistance and Is Biased by Strong Interference of Hypermutation
Dauwe, K., Staelens, D., Vancoillie, L., Mortier, V., & Verhofstede, C. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00030-16 · Cited by 24
Mechanisms of HIV-1 Control
Soliman, M., Srikrishna, G., & Balagopal, A. (2017) · Current HIV/AIDS Reports · doi:10.1007/s11904-017-0357-9 · Cited by 28
Prospects in Innate Immune Responses as Potential Control Strategies against Non-Primate Lentiviruses
de Pablo-Maiso, L., Doménech, A., Echeverría, I., Gómez-Arrebola, C., de Andrés, D., Rosati, S., Gómez‐Lucía, E., & Reina, R. (2018) · Viruses · doi:10.3390/v10080435 · Cited by 25
Dual Functionality of HIV-1 Vif in APOBEC3 Counteraction and Cell Cycle Arrest
Salamango, D. J., & Harris, R. S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.622012 · Cited by 26
Degradation-Independent Inhibition of APOBEC3G by the HIV-1 Vif Protein
Stupfler, B., Verriez, C., Gallois‐Montbrun, S., Marquet, R., & Paillart, J. (2021) · Viruses · doi:10.3390/v13040617 · Cited by 28
Evolution of the Primate APOBEC3A Cytidine Deaminase Gene and Identification of Related Coding Regions
Henry, M., Terzian, C., Peeters, M., Wain–Hobson, S., & Vartanian, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030036 · Cited by 24
A functional conserved intronic G run in HIV-1 intron 3 is critical to counteract APOBEC3G-mediated host restriction
Widera, M., Hillebrand, F., Erkelenz, S., Vasudevan, A. A. J., Münk, C., & Schaal, H. (2014) · Retrovirology · doi:10.1186/preaccept-1252941606128392 · Cited by 25
Alternative Induction of Meiotic Recombination From Single-Base Lesions of DNA Deaminases
Pauklin, S., Burkert, J., Martin, J. S., Osman, F., Weller, S., Boulton, S. J., Whitby, M. C., & Petersen‐Mahrt, S. K. (2009) · Genetics · doi:10.1534/genetics.109.101683 · Cited by 24
Production of Infectious SIVagm from Human Cells Requires Functional Inactivation but Not Viral Exclusion of Human APOBEC3G
Takeuchi, H., Kao, S., Miyagi, E., Khan, M. A., Buckler-White, A. J., Plishka, R. J., & Strebel, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408987200 · Cited by 24
New insights into the role of Vif in HIV-1 replication.
Schröfelbauer, B., Yu, Q., & Landau, N. R. (2004) · PubMed · Cited by 24
Deep Sequencing of HPV16 E6 Region Reveals Unique Mutation Pattern of HPV16 and Predicts Cervical Cancer
Ai, W., Wu, C., Jia, L., Xiao, X., Xu, X., Ren, M., Xue, T., Zhou, X., Wang, Y., & Gao, C. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01401-22 · Cited by 23
HPV16 Phylogenetic Variants in Anogenital and Head and Neck Cancers: State of the Art and Perspectives
Galati, L., Bonito, P. D., Marinaro, M., Chiantore, M. V., & Gheit, T. (2024) · Viruses · doi:10.3390/v16060904 · Cited by 22
Expression of APOBEC3G/3F and G-to-A Hypermutation Levels in HIV-1-Infected Children with Different Profiles of Disease Progression
Amoêdo, N. D., Afonso, A. O., Cunha, S. M., de Oliveira, R. H., Machado, E. S., & Soares, M. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024118 · Cited by 23
Exploring the binding mode of HIV-1 Vif inhibitors by blind docking, molecular dynamics and MM/GBSA
Zhou, M., Luo, H., Li, R., & Ding, Z. (2013) · RSC Advances · doi:10.1039/c3ra42291g · Cited by 23
Zinc-mediated binding of a low-molecular-weight stabilizer of the host anti-viral factor apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G
Radwan, M. O., Sonoda, S., Ejima, T., Tanaka, A., Koga, R., Okamoto, Y., Fujita, M., & Otsuka, M. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.07.030 · Cited by 23
Mapping Region of Human Restriction Factor APOBEC3H Critical for Interaction with HIV-1 Vif
Nakashima, M., Tsuzuki, S., Awazu, H., Hamano, A., Okada, A., Ode, H., Maejima, M., Hachiya, A., Yokomaku, Y., Watanabe, N., et al. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.03.019 · Cited by 24
A high rate of polymerization during synthesis of mouse mammary tumor virus DNA alleviates hypermutation by APOBEC3 proteins
Hagen, B., Kraase, M., Indiková, I., & Indik, S. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007533 · Cited by 23
Running Loose or Getting Lost: How HIV-1 Counters and Capitalizes on APOBEC3-Induced Mutagenesis through Its Vif Protein
Münk, C., Jensen, B. O., Zielonka, J., Häussinger, D., & Kamp, C. (2012) · Viruses · doi:10.3390/v4113132 · Cited by 25
APOBEC3G Oligomerization Is Associated with the Inhibition of Both Alu and LINE-1 Retrotransposition
Koyama, T., Arias, J. F., Iwabu, Y., Yokoyama, M., Fujita, H., Sato, H., & Tokunaga, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084228 · Cited by 25
The tyrosine kinases Fyn and Hck favor the recruitment of tyrosine-phosphorylated APOBEC3G into vif-defective HIV-1 particles
Douaisi, M. P., Dussart, S., Courcoul, M., Bessou, G., Lerner, E. C., Decroly, É., & Vigne, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.057 · Cited by 23
Pathogenesis and Treatment of HIV Infection: The Cellular, the Immune System and the Neuroendocrine Systems Perspective
Черешнев, В. А., Bocharov, G. A., Bazhan, S. I., Bachmetyev, B. A., Gainova, I., Likhoshvai, V. A., Argilaguet, J. M., Martínez, J. P., Rump, J. A., Mothe, B., et al. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.779375 · Cited by 25
APOBEC3DE Antagonizes Hepatitis B Virus Restriction Factors APOBEC3F and APOBEC3G
Bouzidi, M. S., Caval, V., Suspène, R., Hallez, C., Pineau, P., Wain–Hobson, S., & Vartanian, J. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.05.022 · Cited by 23
Computational Model and Dynamics of Monomeric Full-Length APOBEC3G
Gorle, S., Pan, Y., Sun, Z., Shlyakhtenko, L. S., Harris, R. S., Lyubchenko, Y. L., & Vuković, L. (2017) · ACS Central Science · doi:10.1021/acscentsci.7b00346 · Cited by 23
HBV triggers APOBEC2 expression through miR‑122 regulation and affects the proliferation of liver cancer cells
Li, A., Wu, J., Zhai, A., Qian, J., Wang, X., Qaria, M. A., Zhang, Q., Li, Y., Fang, Y., Kao, W., et al. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4870 · Cited by 23
Insights into the Structures and Multimeric Status of APOBEC Proteins Involved in Viral Restriction and Other Cellular Functions
Chen, X. S. (2021) · Viruses · doi:10.3390/v13030497 · Cited by 23
DNA-cytosine deaminases: from antibody maturation to antiviral defense
Bhagwat, A. S. (2003) · DNA repair · doi:10.1016/j.dnarep.2003.09.008 · Cited by 23
Single-Stranded DNA Breaks Adjacent to Cytosines Occur during Ig Gene Class Switch Recombination
Arudchandran, A., Bernstein, R. M., & Max, E. E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3223 · Cited by 23
Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells
Littwitz-Salomon, E., Dittmer, U., & Sutter, K. (2016) · Retrovirology · doi:10.1186/s12977-016-0311-8 · Cited by 23
A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction
Duan, S., Wang, S., Song, Y., Gao, N., Meng, L., Gai, Y., Zhang, Y., Wang, S., Wang, C., Yu, B., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013404 · Cited by 23
Altered T-Lymphocyte Biology Following High-Dose Melphalan and Autologous Stem Cell Transplantation With Implications for Adoptive T-Cell Therapy
Mika, T., Ladigan‐Badura, S., Maghnouj, A., Mustafa, B., Klein‐Scory, S., Baraniskin, A., Döhring, S., Fuchs, I., Ehl, S. R., Hahn, S. A., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.568056 · Cited by 23
An overview of intracellular interactions between immunodeficiency viruses and their hosts
Bieniasz, P. D. (2012) · AIDS · doi:10.1097/qad.0b013e328353bd04 · Cited by 22
Synonymous mutations in stem-loop III of Rev responsive elements enhance HIV-1 replication impaired by primary mutations for resistance to enfuvirtide
Ueno, M., Kodama, E. N., Shimura, K., Sakurai, Y., Kajiwara, K., Sakagami, Y., Oishi, S., Fujii, N., & Matsuoka, M. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.02.002 · Cited by 22
Regulation of vif mRNA Splicing by Human Immunodeficiency Virus Type 1 Requires 5′ Splice Site D2 and an Exonic Splicing Enhancer To Counteract Cellular Restriction Factor APOBEC3G
Mandal, D., Exline, C. M., Feng, Z., & Stoltzfus, C. M. (2009) · Journal of Virology · doi:10.1128/jvi.02231-08 · Cited by 22
Role of APOBEC3F Gene Variation in HIV-1 Disease Progression and Pneumocystis Pneumonia
An, P., Penugonda, S., Thorball, C. W., Bartha, I., Goedert, J. J., Donfield, S. M., Buchbinder, S., Binns-Roemer, E. A., Kirk, G. D., Zhang, W., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005921 · Cited by 24
Impact of TRIM5α in vivo
Nakayama, E. E., & Shioda, T. (2015) · AIDS · doi:10.1097/qad.0000000000000812 · Cited by 24
A New Class of Antiretroviral Enabling Innate Immunity by Protecting APOBEC3 from HIV Vif-Dependent Degradation
Bennett, R. P., Salter, J. D., & Smith, H. C. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.03.004 · Cited by 24
HIV-1 restriction by endogenous APOBEC3G in the myeloid cell line THP-1
Ikeda, T., Molan, A. M., Jarvis, M. C., Carpenter, M. A., Salamango, D. J., Brown, W. L., & Harris, R. S. (2019) · Journal of General Virology · doi:10.1099/jgv.0.001276 · Cited by 24
Lentiviral Vectors
Loewen, N. A., & Poeschla, E. M. (2005) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_007 · Cited by 22
Pharmacogenomics and HIV Therapeutics
Haas, D. W. (2005) · The Journal of Infectious Diseases · doi:10.1086/429303 · Cited by 22
Structural insights into RNA bridging between HIV-1 Vif and antiviral factor APOBEC3G
Kouno, T., Shibata, S., Shigematsu, M., Hyun, J., Kim, T. G., Matsuo, H., & Wolf, M. (2023) · Nature Communications · doi:10.1038/s41467-023-39796-5 · Cited by 23
Involvement of Human Cellular Proteins and Structures in Realization of the HIV Life Cycle: A Comprehensive Review, 2024
Shchemelev, A. N., Davydenko, V. S., Ostankova, Y. V., Reingardt, D. E., Николаевна, С. Е., Zueva, E. B., & Тотолян, А. А. (2024) · Viruses · doi:10.3390/v16111682 · Cited by 24
Feline immunodeficiency virus env gene evolution in experimentally infected cats
Kraase, M., Sloan, R., Klein, D., Logan, N. A., McMonagle, L., Biek, R., Willett, B. J., & Hosie, M. J. (2009) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2009.10.015 · Cited by 21
Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3
Minkah, N. K., Chavez, K., Shah, P., MacCarthy, T., Chen, H., Landau, N. R., & Krug, L. T. (2014) · Virology · doi:10.1016/j.virol.2014.02.022 · Cited by 21
Efficient Vpu-Mediated Tetherin Antagonism by an HIV-1 Group O Strain
Mack, K., Starz, K., Sauter, D., Langer, S., Bibollet‐Ruche, F., Learn, G. H., Stürzel, C. M., Leoz, M., Plantier, J., Geyer, M., et al. (2017) · Journal of Virology · doi:10.1128/jvi.02177-16 · Cited by 22
The DNA damage induced by the Cytosine Deaminase APOBEC3A Leads to the production of ROS
Niocel, M., Appourchaux, R., Nguyen, X.-N., Delpeuch, M., & Cimarelli, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-40941-8 · Cited by 21
Structural basis of substrate specificity in human cytidine deaminase family APOBEC3s
Hou, S., Lee, J. M., Myint, W., Matsuo, H., Yılmaz, N. K., & Schiffer, C. A. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100909 · Cited by 22
APOBEC3G directly binds Hepatitis B virus core protein in cell and cell free systems
Zhao, D., Wang, X., Lou, G., Peng, G., Li, J., Zhu, H., Chen, F., Li, S., Liu, D., Chen, Z., et al. (2010) · Virus Research · doi:10.1016/j.virusres.2010.05.009 · Cited by 21
Vif-deficient HIV reverse transcription complexes (RTCs) are subject to structural changes and mutation of RTC-associated reverse transcription products
Carr, J. M., Davis, A. J., Coolen, C., Cheney, K. M., Burrell, C. J., & Li, P. (2006) · Virology · doi:10.1016/j.virol.2006.03.027 · Cited by 21
Trypanosomes lacking uracil-DNA glycosylase are hypersensitive to antifolates and present a mutator phenotype
Castillo‐Acosta, V. M., Aguilar, F., Vidal, A. E., Navarro, M., Ruiz-Pérez, L. M., & González‐Pacanowska, D. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.06.014 · Cited by 21
Gene Transfer to the Central Nervous System: Current State of the Art of the Viral Vectors
Kremer, E. J. (2005) · Current Genomics · doi:10.2174/1389202053202111 · Cited by 21
Apolipoprotein B mRNA editing enzyme catalytic polypeptide‐like family genes activation and regulation during tumorigenesis
Gao, J., Choudhry, H., & Cao, W. (2018) · Cancer Science · doi:10.1111/cas.13658 · Cited by 22
Irreversible inner ear damage from rock music.
Bohne, B. A., Ward, P. H., & Fernández, C. (1976) · PubMed · Cited by 21
Breaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives
Thippeshappa, R., Ruan, H., & Kimata, J. T. (2012) · Biology · doi:10.3390/biology1020134 · Cited by 20
Characterization of RNA binding and chaperoning activities of HIV-1 Vif protein
Sleiman, D., Bernacchi, S., Guerrero, S. X., Brachet, F., Larue, V., Paillart, J., & Tisné, C. (2014) · RNA Biology · doi:10.4161/rna.29546 · Cited by 24
HIV restriction factor APOBEC3G binds in multiple steps and conformations to search and deaminate single-stranded DNA
Morse, M., Naufer, M. N., Feng, Y., Chelico, L., Rouzina, I. F., & Williams, M. C. (2019) · eLife · doi:10.7554/elife.52649 · Cited by 20
APOBEC3G expression is correlated with poor prognosis in colon carcinoma patients with hepatic metastasis.
Lan, H., Jin, K., Gan, M., Wen, S., Bi, T., Zhou, S., Zhu, N., Teng, L., & Yu, W. (2014) · Europe PMC (PubMed Central) · Cited by 20
Possible Footprints of APOBEC3F and/or Other APOBEC3 Deaminases, but Not APOBEC3G, on HIV-1 from Patients with Acute/Early and Chronic Infections
Armitage, A. E., Deforche, K., Welch, J. J., Laethem, K. V., Camacho, R. J., Rambaut, A., & Iversen, A. K. N. (2014) · Journal of Virology · doi:10.1128/jvi.01460-14 · Cited by 20
In-depth analysis of G-to-A hypermutation rate in HIV-1 env DNA induced by endogenous APOBEC3 proteins using massively parallel sequencing
Knoepfel, S. A., Giallonardo, F. D., Däumer, M., Thielen, A., & Metzner, K. J. (2010) · Journal of Virological Methods · doi:10.1016/j.jviromet.2010.11.016 · Cited by 20
The host environment drives HIV‐1 fitness
van Opijnen, T., & Berkhout, B. (2005) · Reviews in Medical Virology · doi:10.1002/rmv.472 · Cited by 20
HIV-1 Replication in Human Immune Cells Is Independent of TAR DNA Binding Protein 43 (TDP-43) Expression
Nehls, J., Koppensteiner, H., Brack‐Werner, R., Floß, T., & Schindler, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105478 · Cited by 20
Detection of pretreatment minority HIV-1 reverse transcriptase inhibitor-resistant variants by ultra-deep sequencing has a limited impact on virological outcomes
Su, B., Zheng, X. M., Liu, Y., Liu, L., Xin, R., Lu, H., Huang, C., Bai, L., Mammano, F., Zhang, T., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky561 · Cited by 20
Development and characterization of a triple combination gene therapy vector inhibiting HIV‐1 multiplication
Asparuhova, M. B., Barde, I., Trono, D., Schranz, K., & Schümperli, D. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1238 · Cited by 20
Self-citation
Intracellular immunity to HIV-1: newly defined retroviral battles inside infected cells
Zheng, Y., & Peterlin, B. M. (2005) · Retrovirology · doi:10.1186/1742-4690-2-25 · Cited by 20
Dual role of host cell factors in HIV-1 replication: restriction and enhancement of the viral cycle.
Coiras, M., López‐Huertas, M. R., del Cojo, M. S., Mateos, E., & Alcamı́, J. (2010) · PubMed · Cited by 19
Ubiquitination and SUMOylation in HIV Infection: Friends and Foes
Colomer-Lluch, M., Castro‐Gonzalez, S., & Serra-Moreno, R. (2019) · Current Issues in Molecular Biology · doi:10.21775/cimb.035.159 · Cited by 21
Loop 1 of APOBEC3C Regulates its Antiviral Activity against HIV-1
Vasudevan, A. A. J., Balakrishnan, K., Gertzen, C. G. W., Borvető, F., Zhang, Z., Sangwiman, A., Held, U., Küstermann, C., Banerjee, S., Schumann, G. G., et al. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.10.014 · Cited by 19
APOBEC3 family proteins as drivers of virus evolution
Jonathan, M., & Ikeda, T. (2023) · Frontiers in Virology · doi:10.3389/fviro.2023.1332010 · Cited by 20
C→U transition biases in SARS-CoV-2: still rampant 4 years from the start of the COVID-19 pandemic
Peter Simmonds, K. (2024) · mBio · doi:10.1128/mbio.02493-24 · Cited by 19
Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo
Barrett, B. S., Guo, K., Harper, M. S., Li, S. X., Heilman, K. J., Davidson, N. O., & Santiago, M. L. (2014) · Virology · doi:10.1016/j.virol.2014.09.006 · Cited by 19
Accessory Genes Confer a High Replication Rate to Virulent Feline Immunodeficiency Virus
Troyer, R. M., Thompson, J., Elder, J. H., & VandeWoude, S. (2013) · Journal of Virology · doi:10.1128/jvi.00752-13 · Cited by 19
Alpha-enolase in viral target cells suppresses the human immunodeficiency virus type 1 integration
Kishimoto, N., Yamamoto, K., Iga, N., Kirihara, C., Abe, T., Takamune, N., & Misumi, S. (2020) · Retrovirology · doi:10.1186/s12977-020-00539-9 · Cited by 19
Crystal Structure of a Soluble APOBEC3G Variant Suggests ssDNA to Bind in a Channel that Extends between the Two Domains
Maiti, A., Myint, W., Delviks‐Frankenberry, K. A., Hou, S., Kanai, T., Balachandran, V., Rodriguez, C. S., Tripathi, R., Yılmaz, N. K., Pathak, V. K., et al. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.10.020 · Cited by 19
Deaminase-Independent Mode of Antiretroviral Action in Human and Mouse APOBEC3 Proteins
Hakata, Y., & Miyazawa, M. (2020) · Microorganisms · doi:10.3390/microorganisms8121976 · Cited by 21
Isolation of a TRAIL Antagonist from the Serum of HIV-infected Patients
Schnepple, D. J., Shepard, B. D., Bren, G. D., Cummins, N. W., Natesampillai, S., Trushin, S., Algeciras-Schimnich, A., Meng, X. W., Sainski, A. M., Rizza, S. A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.274639 · Cited by 19
APOBEC3G Inhibits HIV-1 RNA Elongation by Inactivating the Viral Trans-Activation Response Element
Nowarski, R., Prabhu, P., Kenig, E., Smith, Y., Britan‐Rosich, E., & Kotler, M. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.05.012 · Cited by 22
APOBEC3 Proteins and Porcine Endogenous Retroviruses
Dörrschuck, E., Münk, C., & Tönjes, R. R. (2008) · Transplantation Proceedings · doi:10.1016/j.transproceed.2008.03.032 · Cited by 19
Characterization of an Amino-Terminal Dimerization Domain from Retroviral Restriction Factor Fv1
Bishop, K. N., Mortuza, G. B., Howell, S. A., Yap, M. W., Stoye, J. P., & Taylor, I. A. (2006) · Journal of Virology · doi:10.1128/jvi.00395-06 · Cited by 19
Powerful mutators lurking in the genome
Petit, V., Vartanian, J., & Wain–Hobson, S. (2008) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2008.0272 · Cited by 19
Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1
Pery, E., Sheehy, A. M., Nebane, N. M., Misra, V., Mankowski, M. K., Rasmussen, L. A., White, E. L., Ptak, R. G., & Gabuzda, D. H. (2015) · Virology · doi:10.1016/j.virol.2015.06.014 · Cited by 22
Ring Finger Protein ZIN Interacts with Human Immunodeficiency Virus Type 1 Vif
Feng, F., Davis, A. J., Lake, J.-A., Carr, J. M., Xia, W., Burrell, C. J., & Li, P. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10574-10581.2004 · Cited by 19
Human Chromosome 2 Carries a Gene Required for Production of Infectious Human Immunodeficiency Virus Type 1
Coskun, A. K., van Maanen, M., Nguyen, V., & Sutton, R. E. (2006) · Journal of Virology · doi:10.1128/jvi.80.7.3406-3415.2006 · Cited by 19
Non‐redundancy of cytidine deaminases in class switch recombination
Fugmann, S. D., Rush, J. S., & Schatz, D. G. (2004) · European Journal of Immunology · doi:10.1002/eji.200324418 · Cited by 19
Rationalisation of the Differences between APOBEC3G Structures from Crystallography and NMR Studies by Molecular Dynamics Simulations
Autore, F., Bergeron, J. R. C., Malim, M. H., Fraternali, F., & Huthoff, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011515 · Cited by 18
Evidence linking APOBEC3B genesis and evolution of innate immune antagonism by gamma-herpesvirus ribonucleotide reductases
Moraes, S. N., Becker, J. T., Moghadasi, S. A., Shaban, N. M., Auerbach, A. A., Cheng, A. Z., & Harris, R. S. (2022) · eLife · doi:10.7554/elife.83893 · Cited by 19
Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles
Ajoge, H. O., Renner, T. M., Bélanger, K., Greig, M., Dankar, S. K., Kohio, H. P., Coleman, M. D., Ndashimye, E., Arts, E. J., Langlois, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35379-y · Cited by 20
Concomitant Lethal Mutagenesis of Human Immunodeficiency Virus Type 1
Dapp, M. J., Holtz, C. M., & Mansky, L. M. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.03.003 · Cited by 19
Loci Polymorphisms of the APOBEC3G Gene in HIV Type 1-Infected Brazilians
Bizinoto, M. C., Leal, E. D. S., Diaz, R. S., & Janini, L. M. (2010) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2010.0146 · Cited by 18
OrfA Downregulates Feline Immunodeficiency Virus Primary Receptor CD134 on the Host Cell Surface and Is Important in Viral Infection
Hong, Y., Fink, E. A., Hu, Q., Kiosses, W. B., & Elder, J. H. (2010) · Journal of Virology · doi:10.1128/jvi.00434-10 · Cited by 18
Virion-incorporated alpha-enolase suppresses the early stage of HIV-1 reverse transcription
Kishimoto, N., Iga, N., Yamamoto, K., Takamune, N., & Misumi, S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.096 · Cited by 20
Human APOBEC3G Prevents Emergence of Infectious Endogenous Retrovirus in Mice
Treger, R. S., Tokuyama, M., Dong, H., Salas-Briceno, K., Ross, S. R., Kong, Y., & Iwasaki, A. (2019) · Journal of Virology · doi:10.1128/jvi.00728-19 · Cited by 18
DNA and RNA editing of retrotransposons accelerate mammalian genome evolution
Knisbacher, B. A., & Levanon, E. Y. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12713 · Cited by 18
The effect of allogeneic in vitro stimulation and in vivo immunization on memory CD4 + T‐cell APOBEC3G expression and HIV‐1 infectivity
Pido-Lopez, J., Wang, Y., Seidl, T., Babaahmady, K., Vaughan, R., & Lehner, T. (2009) · European Journal of Immunology · doi:10.1002/eji.200939228 · Cited by 18
Lentiviral Vif: Viral Hijacker of the Ubiquitin-Proteasome System
Ehrlich, E. S., & Yu, X.-F. (2006) · International Journal of Hematology · doi:10.1532/ijh97.06013 · Cited by 18
APOBEC3 proteins and genomic stability
Narvaiza, I., Landry, S., & Weitzman, M. D. (2012) · Cell Cycle · doi:10.4161/cc.11.1.18706 · Cited by 18

Authors: Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., & Trono, D.
Affiliations: University of Geneva (CH)
Corresponding author: Trono, Didier
ORCID: Mangeat, Bastien
Turelli, Priscilla
Caron, Gersende
Trono, Didier
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2003-05-28
Volume: 424
Issue: 6944
Pages: 99-103
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature01709
OpenAlex: W1966343819
Cited by: 1,486
References: 28
Citations by year: 2026: 20 · 2025: 29 · 2024: 23 · 2023: 28 · 2022: 25 · 2021: 43 · 2020: 37 · 2019: 53 · 2018: 49 · 2017: 56 · 2016: 58 · 2015: 58 · 2014: 79 · 2013: 87 · 2012: 97
FWCI: 36.98
Type: journal article
Language: en
Open access: green
infoscience.epfl.ch
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
Topics: Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords: APOBEC3G, HIV-1 Vif, APOBEC1, cytosine deamination, reverse transcription, G-to-A hypermutation, retrovirus restriction, T cells, RNA editing
MeSH terms: APOBEC-3G Deaminase, Antiviral Agents, Base Sequence, Cell Line, Cytidine Deaminase, DNA, Viral, Humans, Molecular Sequence Data, Nucleoside Deaminases, Proteins, Repressor Proteins, RNA, Messenger, Transcription, Genetic, Virus Replication, HIV-1, Mutagenesis, Gene Products, vif, Point Mutation, RNA Editing, Viral Load, vif Gene Products, Human Immunodeficiency Virus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks